3M chose Bryan Hanson to implement the spinoff of 3M’s health care business, which posted $8.4 billion in sales in 2022. Hanson joined 3M in September after serving as CEO of Zimmer Biomet, a global medical technology company, since 2017. Previously, he was president of Medtronic’s minimally invasive therapies group. Hanson, a Walgreens Boots Alliance board member, will leverage his health care business knowledge in shaping and executing a growth strategy. Hanson’s mandate for Solventum: agility, greater innovation, and increased sales.

Return to TCB 100 for 2024